Status:
COMPLETED
Muscle Selection for Botulinum Toxin A Injection in Poststroke Elbow Flexor Spasticity
Lead Sponsor:
Izmir Katip Celebi University
Conditions:
Muscle Spasticity
Eligibility:
All Genders
18+ years
Brief Summary
Botulinum toxin A (BoNT A) has been reported to be effective in the treatment of elbow flexor spasticity. Although BoNT A is an efficacious treatment option, there is a debate in the selection of targ...
Detailed Description
Botulinum neurotoxin A (BoNT A) has been reported to be effective in the treatment of elbow flexor spasticity. In the treatment of poststroke elbow flexor spasticity with BoNT A, three main muscles in...
Eligibility Criteria
Inclusion
- Chronic (equal to or upper than 1 year) stroke patients with position of elbow flexion and forearm pronation while standing or sitting
- Grade 2 or 3 elbow flexor spasticity and grade 1 to 3 forearm pronator spasticity according to Modified Ashworth Scale
- Stage 2 or 3 Brunnstrom's motor recovery stage of upper extremity
- To agree to participate in the study
Exclusion
- \<18 years old
- Pregnancy
- Botulinum toxin injection within the last three months
- Presence of elbow contracture
- History of operation to spastic upper extremity
- Spasticity due to other causes other than stroke
- Do not agree to participate in the study
Key Trial Info
Start Date :
May 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT04036981
Start Date
May 10 2019
End Date
June 1 2021
Last Update
June 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
İlker Şengül
Izmir, In the USA Or Canada, Please Select..., Turkey (Türkiye), 35360